Please assess the completion status of the following clinical trial:

Trial Title: Phase 3 Efficacy and Safety of VVZ-149 Injections for Postoperative Pain Following Laparoscopic Colectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women who are at least 18 years of age~* Female subjects who are not pregnant or breastfeeding~* Subjects undergoing a planned first laparoscopic colectomy~* Subjects classified in American Society of Anesthesiologists (ASA) risk class of I or II~* Subjects who report the pain intensity ≥ 5 on the NRS measured after surgery~* Subjects who have the ability to understand study procedures and communicate clearly with the investigator and staff~* Subjects who provide written informed consent prior to participation in the study~Key Exclusion Criteria:~* Subjects undergoing emergency or unplanned surgery~* Subjects who had a previous laparoscopic colectomy procedure, or who had any laparoscopic resection procedure~* Subjects with pre-existing conditions causing preoperative pain at the site of surgery~* Female subjects who are pregnant or breastfeeding~* Diagnosis of chronic pain (e.g., persistent pain with the intensity of NRS ≥ 5 at baseline)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- VVZ-149 Injections (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).